Skip to main content
Premium Trial:

Request an Annual Quote

Jubilant Licenses Pathway Database to Dutch Pharmaceutical Company Solvay

NEW YORK, May 4 (GenomeWeb News) - Solvay Pharmaceuticals has licensed Jubilant Biosys' pathway-analysis database, Bangalore, India-based Jubilant said yesterday.

 

Under the agreement, Solvay, based in the Netherlands, has taken a license to Jubilant's PathArt, a database of manually curated pathways and interactions.

 

PathArt covers more than 200,000 biological interactions with relevance to 28 diseases and 15 physiological states.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.